Plasma TF activity at 6 months post-AMI differed between those with adverse versus reverse LV remodeling (OR 0.960, 95% CI: 0.931-0.991; p=0.011) independent of cardiovascular risk factors, including age, sex, ethnicity, hypertension, dyslipidaemia, diabetes mellitus and smoking. This evidence concerns the gene TF and hypertensive disorder.